Renaissance Technologies, founded by the late Jim Simons, cuts its Tesla and Nvidia stakes while raising its GameStop ...

It also brings support for 4K 120fps or 8K 60fps video capture in the AV1 codec, utilising the eighth-generation NVIDIA ...

Nvidia today announced plans to start capping the number of hours that GeForce NOW players can game each month, with the ...

Oct. 26 (UPI) --Chip-maker Nvidia on Friday briefly became the world's most valuable company after surpassing Apple in total market value, but Apple regained its top position by the close of trading.

Oct 25 (Reuters) - Nvidia (NVDA.O), opens new tab dethroned Apple (AAPL.O), opens new tab as the world's most valuable company on Friday following a record-setting rally in the stock, powered by ...

Nvidia briefly eclipsed Apple to become the world's most valuable company on Friday. It's the first time Nvidia has been the world's largest company since mid-June. Nvidia stock jumped as much as ...

Nvidia's market cap leapfrogs Apple, signaling a new titan in tech. AI supercomputing chips fuel Nvidia's stock surge, hinting at the future of tech dominance. What Happened: On Friday, Nvidia’s ...

Call of Duty: Black Ops 6 was released globally on October 25, 2024, featuring a new Omni-movement game mechanic that revolutionizes the movement system in the game. However, the experience will ...

India, a country "dear" to the world's computer industry, is set to witness 20 times growth in compute capacities in 2024, and will soon be exporting impactful AI solutions, Nvidia founder and CEO ...

The guidance for RTX has remained unchanged for free cash flow, but sales have been increased at the lower end by $500 million and by $250 million at the higher end of the range. Operating segment ...

I finished reviewing an RTX 4050 version of the HP Victus 16 a few weeks ago, but it's the RTX 4070 configuration that's been occupying my thoughts ever since. I spotted its $1,399.99 MSRP ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.